We recommend providing the following details: Medical necessity justification with conservative treatment failure
Moreover, vitamin C intake could also reduce the predominant markers of inflammation and oxidative stress like C-reactive protein, interleukin-6, and malondialdehyde
Increasing data indicate that behavior-based therapies that include one of these drugs can reduce weight more than routine care conditions
Betaine supplementation has been used for over 40 years to support individuals with genetic defects of folate dependent remethylation because betaine is known to increase methionine concentration and aid homocysteine reduction
Currently, there is insufficient evidence to support the use of GLP-1 in treating binge eating disorder, but some studies suggest it may be helpful.18 Ongoing assessment and open discussions about the risks are recommended for this population.19 Clinical Efficacy: Weight Management, Type 2 Diabetes, and Cardiovascular Protection Weight Management Weight loss remains a primary reason individuals begin GLP-1 medications, and the STEP clinical trial program has been instrumental in evaluating the efficacy of semaglutide 2.4 mg for chronic weight management across diverse populations, with study participants recruited from a wide range of countries
**Industry Leaders** Leading companies like Sun Pharma, Cipla, Dr
